Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA approves AbbVie's sNDA for Viekira Pak

April 26, 2016

Cocrystal Pharma begins phase Ia/Ib study of HCV drug candidate

April 26, 2016

BARDA supports continued development of NewLink's Ebola vaccine candidate

April 26, 2016

SIGA enrolls patients in final cohort of phase III trial of tecovirimat

April 26, 2016

hVIVO reports favorable initial data from phase IIa study of PrEP-001 in influenza

April 25, 2016

GlaxoSmithKline and New York University describe antiprotozoal agents

April 25, 2016

FVM-04 neutralizes EBOV and SUDV in animal models

April 25, 2016

BL-84, a genetically optimized banana lectin for influenza

April 25, 2016

Achaogen awarded contract option by NIAID to support LpxC inhibitor research

April 22, 2016

NITD-008 and galidesivir improve survival and reduce viremia in AG129 mouse model of ZIKV infection

April 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...